Trending Now
Orchard Therapeutics PLC – ADR (NASDAQ:ORTX) And MolMed Extend Their Partnership...
Orchard Therapeutics PLC – ADR (NASDAQ:ORTX) announced last week that it extended its multi-year collaboration with MoIMed as its gene therapy development and manufacturing...
Genenta Science (GNTA) Soars on Promising Cancer Treatment Developments
GNTA stock closed with a significant jump of 21.40% today, reaching $6.92 at the closing bell. This surge was fueled by exciting...
WeightWatchers (WW stock) Embraces Compounded Semaglutide, Sending Stock Soaring
WeightWatchers (NASDAQ: WW) recently announced to include compounded semaglutide in its program offerings. This strategic move to expand access to effective weight...
Popular News
Vertex (NASDAQ:VRTX) Announce EMA Type II Variation Marketing Authorization Application For...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has announced that the European Medical agencies have validated its Type II variation Marketing Authorization Application for KAFTRIO®.
MAA for expansion...
MAKE IT MODERN
LATEST REVIEWS
Technical analysis suggest Wall Street seems undecided on Microsoft (NASDAQ:MSFT)
MSFT closed at $286.14, down $3.70 or 1.28% from the previous close of $289.84, indicating a bearish day for the stock. The...
MAKE IT MODERN
PERFORMANCE TRAINING
The US FDA Grants Fast Track Designation For Evofem Biosciences Inc (NASDAQ: EVFM)’s EVO100...
Evofem Biosciences Inc (NASDAQ: EVFM) received fast track designation from the US FDA for its EVO100 to prevent gonorrhea in women.
The US FDA offers...
Health Canada Approves SIGA Technologies Inc.’s (NASDAQ: SIGA) TPOXX as a New Drug...
SIGA Technologies Inc. (NASDAQ: SIGA) has received approval from Health Canada for TPOXX as an exceptional use new drug. The regulatory agency has TPOXX...
Technical analysis suggest Wall Street seems undecided on Microsoft (NASDAQ:MSFT)
MSFT closed at $286.14, down $3.70 or 1.28% from the previous close of $289.84, indicating a bearish day for the stock. The...
Novavax Inc. (NASDAQ: NVAX) Receives Positive Market Reaction Amidst Proxy Campaign Withdrawal
Novavax Inc. (NASDAQ: NVAX) saw a notable increase in its stock price, closing at $15.70, up by 5.30% as of May 22,...
OncoCyte Corp. (NYSEAMERICAN:OCX) Strike a Distribution Deal With ProGenetics in the Commercial Promotion of...
One of the primary goals of OncoCyte Corp. (NYSEAMERICAN:OCX) is to provide solutions to patients diagnosed with different types of cancers. Hence, it is...
MAKE IT MODERN
